Pelvic Floor Disorders Management

Introduction to Treatment Options

• Paroxetine is highly effective for treating premature ejaculation, with daily dosing providing stronger effects than on-demand use, according to the American Urological Association 1
• Paroxetine appears to provide the strongest ejaculation delay among SSRIs, increasing ejaculatory latency time approximately 8.8-fold over baseline, as reported by the American Urological Association 1
• The American College of Radiology recommends pelvic floor physical therapy as a complementary treatment for most pelvic floor disorders, which can be used in conjunction with paroxetine or other medications 2

Medication Considerations

• For premature ejaculation, paroxetine is an appropriate first-line medication, with a recommended starting dose of 10-20 mg daily, according to the American Urological Association 1
• Sertraline is also recommended for the treatment of premature ejaculation, with daily doses of 25-200 mg or situational doses of 50 mg, due to its efficacy in increasing ejaculatory latency, as reported by The Journal of Urology and the American Urological Association 3, 1
• For pelvic pain with concurrent depression/anxiety, paroxetine or sertraline may be considered as potential options, although evidence is limited, as noted by the Journal of Clinical Oncology 4

Contraindications and Precautions

• Patients with a history of bipolar disorder should not take paroxetine or sertraline due to the risk of mania, as warned by the American Urological Association and the American Psychiatric Association 1, 5
• Paroxetine and sertraline should not be used in patients under 24 years old due to the increased risk of suicidal ideation, as reported by the American Urological Association and the American Psychiatric Association 1, 5
• Concurrent use of other serotonergic medications with paroxetine or sertraline is contraindicated due to the risk of serotonin syndrome, as noted by the American Urological Association and The Journal of Urology 1, 1

Monitoring and Side Effects

• Patients taking paroxetine or sertraline should be monitored for sexual side effects that may worsen existing pelvic floor dysfunction, such as decreased libido, erectile dysfunction, delayed orgasm, and anorgasmia, as reported by the Journal of the National Comprehensive Cancer Network and The Journal of Urology 2, 3
• Constipation, a common side effect of paroxetine, may worsen pelvic floor dysfunction, particularly in patients with defecatory disorders, as noted by the Clinical Gastroenterology and Hepatology journal 6
• Higher doses of sertraline may be associated with increased frequency of erectile dysfunction and decreased libido, as well as other adverse effects, as reported by The Journal of Urology 3

Special Considerations

• Paroxetine should be avoided in patients taking tamoxifen due to drug interactions through CYP2D6 inhibition, as reported by the Journal of the National Comprehensive Cancer Network 7
• Patients with complex pelvic floor dysfunction should consult with specialists in urology, urogynecology, or pelvic floor physical therapy before initiating paroxetine or sertraline, as recommended by the Journal of Clinical Oncology and the American College of Radiology 4, 8
• The therapeutic plasma concentration range for sertraline is 10-50 ng/mL, with a level of recommendation of 3, as stated by Dialogues in Clinical Neuroscience 9